EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies

Alexandra L Young iD, Jacob W Vogel iD, John L Robinson, Corey T McMillan, Rik Ossenkoppele, David A Wolk, David J Irwin iD, Lauren Elman, Murray Grossman, Virginia M Y Lee, Edward B Lee iD, Oskar Hansson iD

Brain · 03.07.2023 · 146 (7) · 2975-2988

DOI: 10.1093/brain/awad145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 08.05.2023. Verfasst von Alexandra L Young und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK. Hauptthemen laut MEDLINE: Frontotemporal Dementia, TDP-43 Proteinopathies, Alzheimer Disease, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, Medical Research Council, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TAR DNA-binding protein-43 (TDP-43) accumulation is the primary pathology underlying several neurodegenerative diseases. Charting the progression and heterogeneity of TDP-43 accumulation is necessary to better characterize TDP-43 proteinopathies, but current TDP-43 staging systems are heuristic and assume each syndrome is homogeneous. Here, we use data-driven disease progression modelling to derive a fine-grained empirical staging system for the classification and differentiation of frontotemporal lobar degeneration due to TDP-43 (FTLD-TDP, n = 126), amyotrophic lateral sclerosis (ALS, n = 141) and limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) with and without Alzheimer’s disease (n = 304). The data-driven staging of ALS and FTLD-TDP complement and extend previously described human-defined staging schema for ALS and behavioural variant frontotemporal dementia. In LATE-NC individuals, progression along data-driven stages was positively associated with age, but negatively associated with age in individuals with FTLD-TDP. Using only regional TDP-43 severity, our data driven model distinguished individuals diagnosed with ALS, FTLD-TDP or LATE-NC with a cross-validated accuracy of 85.9%, with misclassifications associated with mixed pathological diagnosis, age and genetic mutations. Adding age and SuStaIn stage to this model increased accuracy to 92.3%. Our model differentiates LATE-NC from FTLD-TDP, though some overlap was observed between late-stage LATE-NC and early-stage FTLD-TDP. We further tested for the presence of subtypes with distinct regional TDP-43 progression patterns within each diagnostic group, identifying two distinct cortical-predominant and brainstem-predominant subtypes within FTLD-TDP and a further two subcortical-predominant and corticolimbic-predominant subtypes within ALS. The FTLD-TDP subtypes exhibited differing proportions of TDP-43 type, while there was a trend for age differing between ALS subtypes. Interestingly, a negative relationship between age and SuStaIn stage was seen in the brainstem/subcortical-predominant subtype of each proteinopathy. No subtypes were observed for the LATE-NC group, despite aggregating individuals with and without Alzheimer’s disease and a larger sample size for this group. Overall, we provide an empirical pathological TDP-43 staging system for ALS, FTLD-TDP and LATE-NC, which yielded accurate classification. We further demonstrate that there is substantial heterogeneity amongst ALS and FTLD-TDP progression patterns that warrants further investigation in larger cross-cohort studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaTDP-43 ProteinopathiesAlzheimer DiseaseAmyotrophic Lateral SclerosisFrontotemporal Lobar DegenerationDementiaHumansDNA-Binding Proteins

Stichwörter der Autor:innen

amyotrophic lateral sclerosisfrontotemporal lobar degenerationlimbic-predominant age-related TDP-43 encephalopathymachine learningneuropathological staging

Substanzen

DNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.
  • Centre for Medical Image Computing, Department of Computer Science, University College London, London, WC1V 6LJ, UK.
  • Department of Clinical Sciences, SciLifeLab, Lund University, SE-222 42 Lund, Sweden.
  • Clinical Memory Research Unit, Lund University, SE-222 42 Lund, Sweden.
  • Penn Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

ORCID-Profile: Alexandra L Young, Jacob W Vogel, David J Irwin, Edward B Lee, Oskar Hansson

Förderung

  • NIMH NIH HHS
  • Medical Research Council
  • NIA NIH HHS
  • NINDS NIH HHS
  • MRC Skills Development Fellowship
  • NIH
  • SciLifeLab & Wallenberg Data Driven Life Science Program
  • Penn Udall Center of Excellence in Parkinson's Disease Research

Zitieren

APA

Young, A. L., Vogel, J. W., Robinson, J. L., McMillan, C. T., Ossenkoppele, R., Wolk, D. A., Irwin, D. J., Elman, L., Grossman, M., Lee, V. M. Y., Lee, E. B., & Hansson, O. (2023). Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies. Brain, 146(7), 2975-2988. https://doi.org/10.1093/brain/awad145

Vancouver

Young AL, Vogel JW, Robinson JL, McMillan CT, Ossenkoppele R, Wolk DA, et al. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies. Brain. 2023;146(7):2975-2988. doi:10.1093/brain/awad145

BibTeX
@article{Young2023,
  author = {Young, Alexandra L and Vogel, Jacob W and Robinson, John L and McMillan, Corey T and Ossenkoppele, Rik and Wolk, David A and Irwin, David J and Elman, Lauren and Grossman, Murray and Lee, Virginia M Y and Lee, Edward B and Hansson, Oskar},
  title = {Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {7},
  pages = {2975--2988},
  doi = {10.1093/brain/awad145}
}
Kostenlos starten →